Autopsy report · NCT02824354

Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence.

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“no participants enrolled”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 3
Sponsor: Centre Hospitalier Universitaire, Amiens
Sponsor type: University, hospital or other
Conditions: Cirrhosis; Alcohol Dependence; Nalmefene
Interventions: Nalmefene (Selincro®) 18 mg tablet; placebo
Participants: 0
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.